Indication
Primary mediastinal large B-cell lymphoma
Primary mediastinal large B-cell lymphoma is an aggressive, distinct subtype of non-Hodgkin mature B-cell neoplasm that originates from thymic medullary B cells within the anterior mediastinum. Read more about Primary mediastinal large B-cell lymphoma
9 drugs 4 manufacturers
Drugs that treat it
Common Primary mediastinal large B-cell lymphoma therapies.
KEYTRUDA (pembrolizumab)
YESCARTA (axicabtagene ciloleucel)
BREYANZI (lisocabtagene maraleucel)
BREYANZI (lisocabtagene maraleucel)
BREYANZI CD8 COMPONENT (1OF 2) (lisocabtagene maraleucel, CD8 component, 1 of 2)
BREYANZI CD4 COMPONENT (2OF 2) (lisocabtagene maraleucel, CD4 component, 2 of 2)
BREYANZI CD4 COMPONENT (lisocabtagene maraleucel, CD4 component, 2 of 2)
BREYANZI CD8 COMPONENT (lisocabtagene maraleucel, CD8 component, 1 of 2)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrimary mediastinal large B-cell lymphoma is an aggressive, distinct subtype of non-Hodgkin mature B-cell neoplasm that originates from thymic medullary B cells within the anterior mediastinum.
It most commonly affects adolescents and young adults, demonstrating a marked female predominance.
Pathophysiologically, it shares molecular and genetic features with classic Hodgkin lymphoma, frequently exhibiting compartmentalizing fibrosis, constitutional NF-?B activation, and alterations in chromosome 9p24.1 that lead to PD-L1 overexpression.
Clinically, it typically presents as a rapidly expanding, bulky anterior mediastinal mass that directly invades adjacent thoracic structures, frequently causing cough, dyspnea, pleural or pericardial effusions, and superior vena cava syndrome.
- nih.gov
Primary mediastinal large B-cell lymphoma is an aggressive, distinct subtype of non-Hodgkin mature B-cell neoplasm that originates from thymic medullary B cells within the anterior mediastinum
- cancer.gov
Primary mediastinal large B-cell lymphoma is an aggressive, distinct subtype of non-Hodgkin mature B-cell neoplasm that originates from thymic medullary B cells within the anterior mediastinum Pathophysiologically, it shares molecular and genetic features with classic Hodgkin lymphoma, frequently exhibiting compartmentalizing fibrosis, constitutional NF-κB activation, and alterations in chromosome 9p24.1 that lead to PD-L1 overexpression
- youtube.com
It most commonly affects adolescents and young adults, demonstrating a marked female predominance
- nih.gov
It most commonly affects adolescents and young adults, demonstrating a marked female predominance Clinically, it typically presents as a rapidly expanding, bulky anterior mediastinal mass that directly invades adjacent thoracic structures, frequently causing cough, dyspnea, pleural or pericardial effusions, and superior vena cava syndrome
- nih.gov
Pathophysiologically, it shares molecular and genetic features with classic Hodgkin lymphoma, frequently exhibiting compartmentalizing fibrosis, constitutional NF-κB activation, and alterations in chromosome 9p24.1 that lead to PD-L1 overexpression Clinically, it typically presents as a rapidly expanding, bulky anterior mediastinal mass that directly invades adjacent thoracic structures, frequently causing cough, dyspnea, pleural or pericardial effusions, and superior vena cava syndrome
- nih.gov
Pathophysiologically, it shares molecular and genetic features with classic Hodgkin lymphoma, frequently exhibiting compartmentalizing fibrosis, constitutional NF-κB activation, and alterations in chromosome 9p24.1 that lead to PD-L1 overexpression
- cancer.gov
Clinically, it typically presents as a rapidly expanding, bulky anterior mediastinal mass that directly invades adjacent thoracic structures, frequently causing cough, dyspnea, pleural or pericardial effusions, and superior vena cava syndrome
Personalize your experience
Follow Primary mediastinal large B-cell lymphoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.